Cleared Special

K221041 - Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System (FDA 510(k) Clearance)

Apr 2022
Decision
17d
Days
Class 2
Risk

K221041 is an FDA 510(k) clearance for the Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System. This device is classified as a Percutaneous Catheter, Ultrasound (Class II - Special Controls, product code PPN).

Submitted by Shockwave Medical, Inc. (Santa Clara, US). The FDA issued a Cleared decision on April 25, 2022, 17 days after receiving the submission on April 8, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250. Intended For Ultrasound Wave Enhanced Balloon Dilatation Of Lesions, Including Calcified Lesions, In The Peripheral Vasculature..

Submission Details

510(k) Number K221041 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2022
Decision Date April 25, 2022
Days to Decision 17 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PPN - Percutaneous Catheter, Ultrasound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250
Definition Intended For Ultrasound Wave Enhanced Balloon Dilatation Of Lesions, Including Calcified Lesions, In The Peripheral Vasculature.